Our group develops new platform technologies for cell and gene therapy. To this end, we converge knowledge and techniques of cell/gene/tissue engineering, drug delivery, biomaterials, micro/macro-fluidic bioreactors, transport phenomena, chemical kinetics, computational biology, and bioprocess engineering. Our lab collaborates extensively with biology and clinical experts in hematology, oncology, rheumatology, surgery, and infectious disease to design and execute IND-enabling studies in support of human trials. Animal models of these disease areas are created in-house and pre-clinical studies of experimental therapeutics are performed using advanced principles of pharmacokinetics and pharmacodynamics. The research is conducted with a mindfulness of regulatory science and intellectual property for potential opportunities to translate the work with industrial partners or as a new venture.
Program Faculty
- Biju Parekkadan
- Associate Professor
- Department: Department of Biomedical Engineering
- Phone: 1.8484456563
- Email: biju.parekkadan@rutgers.edu
- Rutgers University
- 599 Taylor Road
- Piscataway, NJ 08855
- Key Words: Cell therapy, genetic engineering, biomaterials science and tissue engineering, bioreactors, drug delivery, biomanufacturing, systems and computational biology
